The various treatments after the end of active surveillance (AS) at the time of the end of the HAROW study (July 2013) and after extended observation of the AS group (April 2015). Of the 468 patients included in the AS group at the beginning of HAROW, 284 (60.7%) were still being treated with AS at the end of HAROW and 201 (42.9%) at the end of the extended observation period.
OP, Radical prostatectomy; RT, radiotherapy; HT, hormone treatment; WW, watchful waiting